Strong Buy HIMS by May 3, 2025.

This is a straight earnings play write-up — Just a thesis I’ve built based on timing, catalyst behavior, and chart structure. # What’s the setup? **Earnings are Monday, May 6 (after hours).** The trade is built around that event using short-dated options (May 9 expiry). # Key points: **1. Timed GLP-1 headline** On April 29, HIMS announced entry into compounded semaglutide (a weight-loss drug space growing rapidly). That announcement came **right before earnings** — companies don’t do that unless they …